Photo from wikipedia
Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and… Click to show full abstract
Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene blue use in treating ifosfamide-induced metabolic encephalopathy is not well established. In this article, we present 2 cases of ifosfamide-induced metabolic encephalopathy responsive to methylene blue treatment.
Keywords:
induced metabolic;
ifosfamide induced;
methylene blue;
metabolic encephalopathy
Journal Title: Journal of Investigative Medicine High Impact Case Reports
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Investigative Medicine High Impact Case Reports
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!